The potential reassessment of cannabinoids, particularly at the federal level, is generating considerable buzz within the sector. A shift away from Schedule I status, often viewed as outdated and hindering innovation, https://kingslists.com/story22089198/marijuana-rescheduling-a-development-catalyst